Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qi Zhu Fang Formula is a traditional Chinese medicine (TCM) herbal formula used primarily for its immunomodulatory and nephroprotective effects. It has been employed clinically to treat hyperuricemic nephropathy and is being studied for its potential to improve the immune microenvironment in breast cancer patients[1][9]. Preclinical studies indicate that it reduces serum uric acid levels, inhibits hepatic xanthine oxidase activity, and protects against renal fibrosis by modulating epithelial-to-mesenchymal transition in the kidneys[1]. The precise herbal composition of this formula may vary by source or clinical context; however, it is distinct from similarly named formulas such as Zheng Qi Support Formula or Sea of Qi Formula.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qi Zhu Fang Formula.